ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PHVS Pharvaris NV

21.29
0.42 (2.01%)
Apr 23 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Pharvaris NV PHVS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.42 2.01% 21.29 20:00:00
Open Price Low Price High Price Close Price Prev Close
20.85 20.54 24.20 21.29 20.87
more quote information »

Recent News

Date Time Source Heading
4/10/202416:10GLOBEPharvaris Reports Fourth Quarter and Full Year 2023..
4/10/202416:08GLOBEPharvaris Appoints David Nassif, J.D., as Chief Financial..
4/04/202406:50GLOBEPharvaris to Present Deucrictibant Clinical Data at the CIIC..
3/18/202406:50GLOBEPharvaris Announces Phase 3 Clinical Study Design for..
3/11/202413:51EDGAR2Form 144 - Report of proposed sale of securities
3/06/202416:40EDGAR2Form F-3ASR - Automatic shelf registration statement of..
3/06/202416:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/06/202406:50GLOBEPharvaris to Present Deucrictibant Clinical Data at Upcoming..
3/05/202406:50GLOBEPharvaris to Participate in the Leerink Global Biopharma..
2/22/202406:50GLOBEPositive Results from CHAPTER-1 Phase 2 Study of..
2/16/202406:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/16/202406:50GLOBEPharvaris Announces Extraordinary Meeting of Shareholders
2/07/202416:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/01/202416:46EDGAR2Form 144 - Report of proposed sale of securities
1/26/202406:50GLOBEPharvaris to Present at the WSAAI Annual Meeting 2024
1/22/202407:35DJNPharvaris Says FDA Lifted Clinical Hold on Application for..
1/22/202406:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/22/202406:50GLOBEPharvaris Announces FDA Lifting of the Clinical Hold of..
1/08/202407:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/05/202406:50GLOBEPharvaris Provides Business Update and Outlines 2024..
1/02/202416:29EDGAR2Form 144 - Report of proposed sale of securities
12/08/202318:00GLOBEPharvaris Presents Deucrictibant Clinical Data and Analysis..
12/08/202316:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/07/202316:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/202316:36EDGAR2Form 144 - Report of proposed sale of securities
12/06/202307:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
12/06/202307:02GLOBEPharvaris Announces Pricing of $300 Million Underwritten..
12/06/202306:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/06/202306:50GLOBEPharvaris Announces Positive Top-line Phase 2 Data from the..
11/30/202306:50GLOBEPharvaris to Present at the GA²LEN UCARE Conference 2023
11/15/202306:50GLOBEPharvaris Appoints Stefan Abele, Ph.D., as Chief Technical..
11/09/202311:00GLOBEPharvaris Presents Deucrictibant Clinical Data and..
11/02/202306:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/02/202306:50GLOBEPharvaris Reports Third Quarter 2023 Financial Results and..
10/30/202306:50GLOBEPharvaris To Present at the ACAAI 2023 Annual Scientific..
10/13/202306:50GLOBEPharvaris To Present at the APAAACI 2023 International..
10/04/202307:34GLOBEPharvaris To Present at the CIIC Fall 2023 Conference
9/19/202316:23EDGAR2Form 144 - Report of proposed sale of securities
9/19/202306:50GLOBEPharvaris To Participate in the 2023 Cantor Global..
9/06/202306:51GLOBEPharvaris To Present at the 18th German Allergy Congress
9/06/202306:50GLOBEPharvaris To Participate in the Morgan Stanley 21st Annual..
9/01/202318:02EDGAR2Form 144 - Report of proposed sale of securities
8/24/202316:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/23/202306:50GLOBEPharvaris To Present at the 2023 HAEi Regional Conference..
8/17/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/09/202319:00EDGAR2Form 144 - Report of proposed sale of securities
8/09/202318:38EDGAR2Form 144 - Report of proposed sale of securities
8/07/202310:16EDGAR2Form F-3 - Registration statement by foreign private issuers
8/07/202306:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/07/202306:50GLOBEPharvaris Reports Second Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock